DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr | ₹1,377 Cr |
What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,600 Cr |
Mar2023 | ₹1,824 Cr |
Mar2022 | ₹2,960 Cr |
Mar2021 | ₹1,984 Cr |
Mar2020 | ₹1,377 Cr |
How is Consolidated Net Profit of DIVIS LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | 44.15 | |
Mar2020 | ₹1,377 Cr | - |
Compare Consolidated Net Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹161,202.3 Cr | 3% | 5.9% | 65% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
MANKIND PHARMA | ₹103,515.0 Cr | 0.6% | 3.1% | 34.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 3% |
5.9% |
65% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses